TACLONEX - 50222-501-06 - (calcipotriene and betamethasone dipropionate)

Alphabetical Index


Drug Information of TACLONEX

Product NDC: 50222-501
Proprietary Name: TACLONEX
Non Proprietary Name: calcipotriene and betamethasone dipropionate
Active Ingredient(s): .5; 50    mg/g; ug/g & nbsp;   calcipotriene and betamethasone dipropionate
Administration Route(s): TOPICAL
Dosage Form(s): SUSPENSION
Coding System: National Drug Codes(NDC)

Labeler Information of TACLONEX

Product NDC: 50222-501
Labeler Name: LEO Pharma Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022185
Marketing Category: NDA
Start Marketing Date: 20080601

Package Information of TACLONEX

Package NDC: 50222-501-06
Package Description: 40 CARTON in 1 CASE (50222-501-06) > 1 BOTTLE in 1 CARTON > 60 g in 1 BOTTLE

NDC Information of TACLONEX

NDC Code 50222-501-06
Proprietary Name TACLONEX
Package Description 40 CARTON in 1 CASE (50222-501-06) > 1 BOTTLE in 1 CARTON > 60 g in 1 BOTTLE
Product NDC 50222-501
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name calcipotriene and betamethasone dipropionate
Dosage Form Name SUSPENSION
Route Name TOPICAL
Start Marketing Date 20080601
Marketing Category Name NDA
Labeler Name LEO Pharma Inc.
Substance Name BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE
Strength Number .5; 50
Strength Unit mg/g; ug/g
Pharmaceutical Classes Vitamin D [Chemical/Ingredient],Vitamin D Analog [EPC],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]

Complete Information of TACLONEX


General Information